Atlas Trials

A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT05407961 · COMPLETED

Trial details

NCT number
NCT05407961
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2022-06-07
Primary completion
2024-01-12
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.